Chenyu Mao
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Inflammatory Biomarkers in Disease Prognosis
- Gastroenterology top 10%
- Gastrointestinal Tumor Research and Treatment
Papers in
- Oncology 29
- Cancer Immunotherapy and Biomarkers 13
- Colorectal Cancer Treatments and Studies 7
- Inflammatory Biomarkers in Disease Prognosis 4
-
- Gastric Cancer Management and Outcomes 13
- Co-authors
- Nong Xu (19 shared papers)Yongfeng Ding (8 shared papers)Yulong Zheng (15 shared papers)Lisong Teng (7 shared papers)Hongyang Yi (4 shared papers)Xinliang Mao (5 shared papers)Biyin Cao (4 shared papers)Xiao Cheng (6 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)ESMO Open (3 papers)Journal of Biological Chemistry (3 papers)Medicine (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Chenyu Mao
55 papers receiving 654 citations
Peers
Comparison fields: 5 of 83
- Oncology 298
- Gastroenterology 41
- Immunology 133
- Cancer Research 74
- Pulmonary and Respiratory Medicine 160
Countries citing papers authored by Chenyu Mao
This map shows the geographic impact of Chenyu Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyu Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyu Mao more than expected).
Fields of papers citing papers by Chenyu Mao
This network shows the impact of papers produced by Chenyu Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyu Mao. The network helps show where Chenyu Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Chenyu Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 54 | |
| 2 | 2010 | 54 | |
| 3 | 2022 | 51 | |
| 4 | 2020 | 49 | |
| 5 | 2020 | 44 | |
| 6 | 1993 | 32 | |
| 7 | 2020 | 31 | |
| 8 | 2019 | 25 | |
| 9 | 2020 | 23 | |
| 10 | 2021 | 20 | |
| 11 | Recent advances in heat shock protein-based cancer vaccines. | 2006 | 18 |
| 12 | 2021 | 17 | |
| 13 | 2022 | 16 | |
| 14 | 2022 | 16 | |
| 15 | Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells. | 1998 | 15 |
| 16 | 2022 | 11 | |
| 17 | Combined use of chemotherapeutics and oncolytic adenovirus in treatment of AFP-expressing hepatocellular carcinoma. | 2009 | 11 |
| 18 | 2019 | 11 | |
| 19 | 2020 | 11 | |
| 20 | 2020 | 10 |
About Chenyu Mao
Chenyu Mao is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Immunology, having authored 61 papers that have together received 661 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (13 papers), Gastric Cancer Management and Outcomes (13 papers), Cancer Research and Treatments (7 papers), Colorectal Cancer Treatments and Studies (7 papers), Gastrointestinal Tumor Research and Treatment (6 papers), Ubiquitin and proteasome pathways (5 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Immunotherapy and Immune Responses (4 papers). The work is most often cited by research in Oncology (298 citations), Gastroenterology (41 citations), Immunology (133 citations), Cancer Research (74 citations) and Pulmonary and Respiratory Medicine (160 citations). Chenyu Mao has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Nong Xu, Yongfeng Ding, Yulong Zheng, Lisong Teng, Hongyang Yi, Xinliang Mao, Biyin Cao, Xiao Cheng, Nong Xu and Lisong Teng. Their work appears in journals such as Journal of Clinical Oncology, ESMO Open, Journal of Biological Chemistry, Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.